133 results on '"Parmar, M. K. B."'
Search Results
2. Using Replicate Observations in Observer Agreement Studies with Binary Assessments
3. Chemotherapy In Non-Small Cell Lung Cancer
4. Clinical trials in ovarian carcinoma: study methodology
5. Multiplicity in clinical trials and other medical studies
6. Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review
7. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
8. BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112
9. Designing randomised trials: both large and small trials are needed
10. Paclitaxel and Cisplatin in Ovarian Cancer
11. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
12. What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
13. Proposal for Changes in Cystoscopic Follow Up of Patients with Bladder Cancer and Adjuvant Intravesical Chemotherapy.
14. Pathology review and diagnosis of cancer
15. Effect Of Intravesical Mitomycin C On Recurrence Of Newly Diagnosed Superficial Bladder Cancer: Interim Report From The Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)
16. Chemotherapy In Advanced Ovarian Cancer
17. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
18. Paclitaxel and cisplatin in ovarian cancer
19. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
20. Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial
21. Speeding up the Evaluation of New Agents in Cancer
22. Response: Re: Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan-Meier Plots
23. Parenteral oestrogen in the treatment of prostate cancer: a systematic review
24. Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan Meier Plots
25. Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)
26. Evaluation of sample size and power for multi-arm survival trials allowing for non-uniform accrual, non-proportional hazards, loss to follow-up and cross-over
27. Letter to the Editor
28. First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
29. Randomized Trials in Early Prostate Cancer. II: Hormone Therapy and Radiotherapy for Locally Advanced Disease: A Question is Still Unanswered
30. Analysis of messy longitudinal data from a randomized clinical trial
31. No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials.
32. In Reply
33. A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer
34. Assessing Whether to Perform a Confirmatory Randomized Clinical Trial
35. In Reply
36. The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer
37. Survival Analysis--A Practical Approach.
38. Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin
39. Initial Combination Chemotherapy with Cisplatin, Methotrexate and Vinblastine in Locally Advanced Transitional Cell Carcinoma-Response Rate and Pitfalls
40. Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder
41. How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design - a reanalysis of 4 trials.
42. Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer
43. No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial.
44. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
45. Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms.
46. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?
47. Preoperative Radiotherapy in Esophageal Carcinoma: A Meta-Analysis Using Individual Patient Data (Oesophageal Cancer Collaborative Group)
48. Evaluation and Follow-up of Patients with N1-3 M0 or NXM1 Prostate Cancer in Phase III Trials
49. Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer] [3]
50. A phase 3 trial of bevacizumab in ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.